| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |